Clinical Trial Update: N-Acetyl Cysteine Plus Behavioral Therapy for Nicotine Dependent Pathological Gamblers [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating N-Acetyl Cysteine plus behavioral therapy for nicotine dependent gamblers has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gambling
• Tobacco Use Disorder

Drugs mentioned

• N-Acetyl-Cysteine (N-acetylcysteine)

Snippet

Sponsor: University of Chicago | Conditions: Gambling, Tobacco Use Disorder | Phase 2 | Status: COMPLETED | Results posted: 2017-07-07